Physician profile
Christopher Dru
NPI 1346531563
$5,629.91
in general payments reported to CMS, 2019-2025
42 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $929 · 2020: $345 · 2021: $995 · 2022: $1,328 · 2023: $1,760 · 2024: $274.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,578 · Travel and Lodging: $447 · Education: $8.58.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,577.60 |
| Travel and Lodging | $447.44 |
| Education | $8.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $1,028.14 | 2019-2023 | Xtandi, Myrbetriq |
| Intuitive Surgical, INC. | $974.20 | 2020-2023 | Da Vinci Surgical System |
| Abbvie INC. | $447.44 | 2019-2023 | Botox, Avycaz, Lupron Depot |
| Coloplast Corp | $394.91 | 2021-2024 | |
| Endo Pharmaceuticals INC. | $266.72 | 2019-2024 | Xiaflex |
| Janssen Biotech, INC. | $213.76 | 2019-2023 | Erleada |
| Sumitomo Pharma America, INC. | $185.21 | 2023 | Orgovyx, Gemtesa |
| Blue Earth Diagnostics | $164.83 | 2019-2023 | |
| Myriad Genetic Laboratories, INC. | $159.37 | 2022-2023 | Prolaris |
| Amgen INC. | $150.48 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $143.91 | 2019-2023 | |
| Progenics Pharmaceuticals, INC. | $141.86 | 2022-2024 | Pylarify |
| Myovant Sciences INC. | $108.40 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $103.69 | 2022-2023 | Lynparza, Welireg, Keytruda |
| C. R. Bard, INC. & Subsidiaries | $94.43 | 2019 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Dru listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.